Prevalence of obsessive-compulsive disorders (OCD) symptoms among health care workers in COVID-19 pandemic: a systematic review and meta-analysis.

COVID-19 Health care workers Meta-analysis OCD Obsessive compulsive disorder symptoms Systematic reviews

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
21 Nov 2023
Historique:
received: 06 02 2023
accepted: 06 11 2023
medline: 23 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Obsessive Compulsive Disorder (OCD) symptoms, are among the serious mental health challenges that Health Care Workers (HCWs) faced during the COVID-19 pandemic. As these symptoms reduce the mental well-being and effectiveness of HCWs which are followed by poor health outcomes for patients, the aim of this systematic review and meta-analysis was to determine the prevalence of OCD symptoms among HCWs worldwide. PubMed, Google Scholar, Cochrane, Scopus, Web of Science, ProQuest, Emerald, and ERIC databases were searched using related keywords till the end of October 2021. Observational studies about the prevalence of OCD symptoms among healthcare workers during the COVID-19 pandemic were screened and evaluated. In order to assess the quality of studies, the Newcastle-Ottawa scale (NOS) checklist was used. The effect measure was the prevalence rate with a 95% confidence interval (CI). A total of 7864 individuals from 11 studies were included. The range of OCD symptoms prevalence across these studies was from 0.07 to 0.47. Due to the high heterogeneity between the studies (I The pooled prevalence of OCD symptoms was 29% among the HCWs during the COVID-19 pandemic. This prevalence was higher than the general population according to the pre-pandemic literature, but lower than the recent reports amid the pandemic. Psychosocial interventions are suggested to be designed and implemented in such conditions.

Sections du résumé

BACKGROUND BACKGROUND
Obsessive Compulsive Disorder (OCD) symptoms, are among the serious mental health challenges that Health Care Workers (HCWs) faced during the COVID-19 pandemic. As these symptoms reduce the mental well-being and effectiveness of HCWs which are followed by poor health outcomes for patients, the aim of this systematic review and meta-analysis was to determine the prevalence of OCD symptoms among HCWs worldwide.
METHODS METHODS
PubMed, Google Scholar, Cochrane, Scopus, Web of Science, ProQuest, Emerald, and ERIC databases were searched using related keywords till the end of October 2021. Observational studies about the prevalence of OCD symptoms among healthcare workers during the COVID-19 pandemic were screened and evaluated. In order to assess the quality of studies, the Newcastle-Ottawa scale (NOS) checklist was used. The effect measure was the prevalence rate with a 95% confidence interval (CI).
RESULTS RESULTS
A total of 7864 individuals from 11 studies were included. The range of OCD symptoms prevalence across these studies was from 0.07 to 0.47. Due to the high heterogeneity between the studies (I
CONCLUSIONS CONCLUSIONS
The pooled prevalence of OCD symptoms was 29% among the HCWs during the COVID-19 pandemic. This prevalence was higher than the general population according to the pre-pandemic literature, but lower than the recent reports amid the pandemic. Psychosocial interventions are suggested to be designed and implemented in such conditions.

Identifiants

pubmed: 37990311
doi: 10.1186/s12888-023-05353-z
pii: 10.1186/s12888-023-05353-z
pmc: PMC10664495
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

862

Subventions

Organisme : Iran University of Medical Sciences
ID : 1400-2-90-21767

Informations de copyright

© 2023. The Author(s).

Références

Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
Compr Psychiatry. 2022 Oct;118:152334
pubmed: 36007340
PLoS One. 2020 May 19;15(5):e0233145
pubmed: 32428041
Psychiatry Res. 1992 Jan;41(1):37-44
pubmed: 1561287
Compr Psychiatry. 2020 Nov;103:152198
pubmed: 32980595
Front Psychiatry. 2022 Mar 25;13:806872
pubmed: 35401266
Nephrology (Carlton). 2010 Sep;15(6):617-24
pubmed: 20883282
Int J Environ Res Public Health. 2019 Nov 11;16(22):
pubmed: 31717906
Psychiatry Res. 2020 Jun;288:112966
pubmed: 32334276
Trends Psychiatry Psychother. 2021 Apr-Jun;43(2):81-84
pubmed: 33503168
Brain Behav Immun. 2022 Mar;101:93-135
pubmed: 34973396
Front Psychiatry. 2022 Nov 04;13:1073768
pubmed: 36405906
PLoS One. 2016 Jul 08;11(7):e0159015
pubmed: 27391946
J Formos Med Assoc. 2017 Apr;116(4):300-305
pubmed: 27424803
Psychother Psychosom. 2020;89(4):242-250
pubmed: 32272480
Front Psychiatry. 2021 Jul 14;12:665019
pubmed: 34335323
J Psychiatr Res. 2021 Sep;141:276-286
pubmed: 34271458
Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):25
pubmed: 33613023
J Obsessive Compuls Relat Disord. 2021 Apr;29:100626
pubmed: 33520614
Soc Psychiatry Psychiatr Epidemiol. 2018 Sep;53(9):897-909
pubmed: 29869691
Front Psychiatry. 2021 Aug 25;12:708698
pubmed: 34512418
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Lancet Psychiatry. 2020 Jun;7(6):e29-e30
pubmed: 32445691
BMJ. 2020 Mar 26;368:m1211
pubmed: 32217624
Sleep Biol Rhythms. 2021;19(2):173-180
pubmed: 33456342
Acta Neuropsychiatr. 2023 Oct;35(5):270-291
pubmed: 36861432
Front Psychol. 2021 Sep 03;12:644212
pubmed: 34539479
J Psychiatr Res. 2022 Apr;148:21-26
pubmed: 35091357
Asian J Psychiatr. 2020 Jun;51:102111
pubmed: 32361388
Iran J Psychiatry. 2020 Jul;15(3):256-259
pubmed: 33193776
Curr Psychiatry Rep. 2021 Oct 6;23(11):71
pubmed: 34613498
Compr Psychiatry. 2020 Jul;100:152174
pubmed: 32388123
Clin Child Psychol Psychiatry. 2022 Jan;27(1):18-34
pubmed: 34171975
Neurosci Biobehav Rev. 2022 Jan;132:1086-1098
pubmed: 34740755
Psychiatry Res. 2020 Nov;293:113363
pubmed: 32798931
Acta Med Iran. 2011;49(10):680-7
pubmed: 22071645
BMC Public Health. 2021 May 29;21(1):1015
pubmed: 34051769
Psychol Health Med. 2021 Jan;26(1):98-106
pubmed: 33305600
JMIR Ment Health. 2020 Sep 25;7(9):e22408
pubmed: 32915764
Australas Psychiatry. 2021 Jun;29(3):326-332
pubmed: 33626303

Auteurs

Neda SoleimanvandiAzar (N)

Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Ali Amirkafi (A)

Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Mohammadreza Shalbafan (M)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Seyyed Amir Yasin Ahmadi (SAY)

Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Shadi Asadzandi (S)

Department of Medical Library and Information Science, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Shiva Shakeri (S)

Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Mahdieh Saeidi (M)

Research Center for Addiction and Risky Behaviors, Iran University of Medical Sciences, Tehran, Iran.

Reza Panahi (R)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Marzieh Nojomi (M)

Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. mnojomi@iums.ac.ir.
Department of Sociology and Anthropology, Nipissing University, North Bay, ON, Canada. mnojomi@iums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH